(3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one

C115H208FN7O31 — CID 161270404

About (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one

(3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one (PubChem CID 161270404) has the molecular formula C115H208FN7O31 and a molecular weight of 2203.94 g/mol. Its IUPAC name is (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one.

Molecular Properties

• Compound Name: (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one
• PubChem CID: 161270404
• Molecular Formula: C115H208FN7O31
• Molecular Weight: 2203.94 g/mol
• Exact Mass: 2202.49
• IUPAC Name: (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one
• SMILES: CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOC2CCCNC2)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOC2CCNC2)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOCCN(C)C)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](C)[C@](C)(O)C[C@@H](C)C(=NOCCCF)[C@H](C)[C@@H](O)[C@]1(C)O
• InChI: InChI=1S/C33H60FNO10.C28H50N2O7.C27H48N2O7.C27H50N2O7/c1-12-24-33(10,40)28(36)20(4)26(35-42-15-13-14-34)18(2)16-31(8,39)22(6)19(3)27(21(5)30(38)44-24)45-25-17-32(9,41-11)29(37)23(7)43-25;1-10-22-28(8,34)25(32)18(4)23(30-37-21-12-11-13-29-15-21)16(2)14-27(7,35-9)20(6)17(3)24(31)19(5)26(33)36-22;1-10-21-27(8,33)24(31)17(4)22(29-36-20-11-12-28-14-20)15(2)13-26(7,34-9)19(6)16(3)23(30)18(5)25(32)35-21;1-12-21-27(8,33)24(31)18(4)22(28-35-14-13-29(9)10)16(2)15-26(7,34-11)20(6)17(3)23(30)19(5)25(32)36-21/h18-25,27-29,36-37,39-40H,12-17H2,1-11H3;16-22,25,29,32,34H,10-15H2,1-9H3;15-21,24,28,31,33H,10-14H2,1-9H3;16-21,24,31,33H,12-15H2,1-11H3/t18-,19-,20+,21-,22-,23+,24-,25+,27+,28-,29+,31-,32-,33-;16-,17-,18+,19-,20-,21?,22-,25-,27-,28-;15-,16-,17+,18-,19-,20?,21-,24-,26-,27-;16-,17-,18+,19-,20-,21-,24-,26-,27-/m1111/s1
• InChIKey: VDSTWIVZHGTSKR-KUAQAULBSA-N
• XLogP: 12.50
• TPSA: 527.75 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 38
• Rotatable Bonds: 22
• Heavy Atoms: 154
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2203.94
LogP ≤ 5	12.50
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	38

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one?

The IUPAC name of (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one (CID 161270404) is (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one.

What is the SMILES notation for (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one?

The canonical SMILES for (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOC2CCCNC2)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOC2CCNC2)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](C)[C@](C)(OC)C[C@@H](C)C(=NOCCN(C)C)[C@H](C)[C@@H](O)[C@]1(C)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](C)[C@](C)(O)C[C@@H](C)C(=NOCCCF)[C@H](C)[C@@H](O)[C@]1(C)O.

What is the InChIKey of (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one?

The InChIKey is VDSTWIVZHGTSKR-KUAQAULBSA-N. The full InChI is InChI=1S/C33H60FNO10.C28H50N2O7.C27H48N2O7.C27H50N2O7/c1-12-24-33(10,40)28(36)20(4)26(35-42-15-13-14-34)18(2)16-31(8,39)22(6)19(3)27(21(5)30(38)44-24)45-25-17-32(9,41-11)29(37)23(7)43-25;1-10-22-28(8,34)25(32)18(4)23(30-37-21-12-11-13-29-15-21)16(2)14-27(7,35-9)20(6)17(3)24(31)19(5)26(33)36-22;1-10-21-27(8,33)24(31)17(4)22(29-36-20-11-12-28-14-20)15(2)13-26(7,34-9)19(6)16(3)23(30)18(5)25(32)35-21;1-12-21-27(8,33)24(31)18(4)22(28-35-14-13-29(9)10)16(2)15-26(7,34-11)20(6)17(3)23(30)19(5)25(32)36-21/h18-25,27-29,36-37,39-40H,12-17H2,1-11H3;16-22,25,29,32,34H,10-15H2,1-9H3;15-21,24,28,31,33H,10-14H2,1-9H3;16-21,24,31,33H,12-15H2,1-11H3/t18-,19-,20+,21-,22-,23+,24-,25+,27+,28-,29+,31-,32-,33-;16-,17-,18+,19-,20-,21?,22-,25-,27-,28-;15-,16-,17+,18-,19-,20?,21-,24-,26-,27-;16-,17-,18+,19-,20-,21-,24-,26-,27-/m1111/s1.

What are the key properties of (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one?

(3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one has a molecular weight of 2203.94 g/mol, XLogP of 12.50, 22 rotatable bonds, 12 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for (3R,5R,6R,7R,9R,11S,12R,13S,14R)-10-[2-(dimethylamino)ethoxyimino]-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-piperidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-7-methoxy-3,5,6,7,9,11,13-heptamethyl-10-pyrrolidin-3-yloxyimino-oxacyclotetradecane-2,4-dione;(3R,4S,5R,6R,7R,9R,11S,12R,13S,14R)-14-ethyl-10-(3-fluoropropoxyimino)-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,7,9,11,13-heptamethyl-oxacyclotetradecan-2-one is sourced from PubChem (CID 161270404), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).